Legislative Progress
Introduced
February 22, 2021
Latest Action
February 23, 2021
Primary Sponsor
Doris O. MatsuiDemocratic(CA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Food Allergy Safety, Treatment, Education, and Research Act of 2021 or the FASTER Act of 2021 This bill expands the definition of major food allergen for purposes of certain food-labeling requirements to specifically include sesame. In addition, the Department of Health and Human Services must report on certain information related to food allergy research and data collection activities.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (11)
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2024 · fourth_quarter · Health Issues
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Client expense: $200,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
Monitor the following: Higher education healthcare related issues, generally NIH program related issues Public health and CDC related issues Adolescent Mental Health related issues Telehealth related issues Graduate Medical Education (GME) H.R.2389/S.1302, Resident Physician Shortage Act of 2023, generally H.R.1202/S.704, Resident Education Deferred Interest Act, generally H.R.4942/S.665 The Conrad State 30 and Physician Access Reauthorization Act, generally Laboratory Developed Tests Organ transplant issues Alabama Area Health Education Centers (AHEC) Nurse reimbursement related issues Hospital at Home Program, Entirety Proposed Cuts to OPPS for Organ Acquisition Cos Disproportionate Share Hospital (DSH) Payments Public Law 117-167, Supreme Court Security Funding Act of 2022, Division A--Creating Helpful Incentives to Produce Semiconductors (CHIPS Act), NSF and Energy related issues Agency for Healthcare Research and Quality related issues IDeA program related issues
Client expense: Not reported · Firm income: $60,000
2024 · fourth_quarter · Health Issues
Monitor the following: Higher education healthcare related issues, generally NIH program related issues Public health and CDC related issues Adolescent Mental Health related issues Telehealth related issues Graduate Medical Education (GME) H.R.2389/S.1302, Resident Physician Shortage Act of 2023, generally H.R.1202/S.704, Resident Education Deferred Interest Act, generally H.R.4942/S.665 The Conrad State 30 and Physician Access Reauthorization Act, generally Laboratory Developed Tests Organ transplant issues Alabama Area Health Education Centers (AHEC) Nurse reimbursement related issues Hospital at Home Program, Entirety Proposed Cuts to OPPS for Organ Acquisition Cos Disproportionate Share Hospital (DSH) Payments Public Law 117-167, Supreme Court Security Funding Act of 2022, Division A--Creating Helpful Incentives to Produce Semiconductors (CHIPS Act), NSF and Energy related issues Agency for Healthcare Research and Quality related issues IDeA program related issues
Client expense: Not reported · Firm income: $30,000
2024 · third_quarter · Health Issues
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Client expense: $160,000 · Firm income: Not reported
2024 · third_quarter · Health Issues
Higher education healthcare related issues, generally NIH program related issues Public health and CDC related issues Adolescent Mental Health related issues Telehealth related issues Graduate Medical Education (GME) H.R.2389/S.1302, Resident Physician Shortage Act of 2023, generally H.R.1202/S.704, Resident Education Deferred Interest Act, generally H.R.4942/S.665 The Conrad State 30 and Physician Access Reauthorization Act, generally Monitor the following: Laboratory Developed Tests Organ transplant issues Alabama Area Health Education Centers (AHEC) Nurse reimbursement related issues Hospital at Home Program, Entirety Proposed Cuts to OPPS for Organ Acquisition Cos Disproportionate Share Hospital (DSH) Payments Public Law 117-167, Supreme Court Security Funding Act of 2022, Division A--Creating Helpful Incentives to Produce Semiconductors (CHIPS Act), NSF and Energy related issues Agency for Healthcare Research and Quality related issues IDeA program related issues
Client expense: Not reported · Firm income: $60,000
| Democratic |
| IL |
| Brendan F. Boyle | Democratic | PA |
| Brian K. Fitzpatrick | Republican | PA |
| Burgess Owens | Republican | UT |
| C. A. Dutch Ruppersberger | Democratic | MD |
| Carolyn B. Maloney | Democratic | NY |
| Chris Pappas | Democratic | NH |
| Conor Lamb | Democratic | PA |
| Cynthia Axne | Democratic | IA |
| David N. Cicilline | Democratic | RI |
| David P. Joyce | Republican | OH |
| Elaine G. Luria | Democratic | VA |
| Gerald E. Connolly | Democratic | VA |
| Grace F. Napolitano | Democratic | CA |
| Grace Meng | Democratic | NY |
| Haley M. Stevens | Democratic | MI |
| Jahana Hayes | Democratic | CT |
| James R. Langevin | Democratic | RI |
| Jamie Raskin | Democratic | MD |
| Janice D. Schakowsky | Democratic | IL |
| Jefferson Van Drew | Republican | NJ |
| Jim Cooper | Democratic | TN |
| Lisa Blunt Rochester | Democratic | DE |
| Lucille Roybal-Allard | Democratic | CA |
| Madeleine Dean | Democratic | PA |
| Marie Newman | Democratic | IL |
| Mark Pocan | Democratic | WI |
| Matt Cartwright | Democratic | PA |
| Mike Gallagher | Republican | WI |
| Mike Levin | Democratic | CA |
| Mondaire Jones | Democratic | NY |
| Nydia M. Velázquez | Democratic | NY |
| Patrick T. McHenry | Republican | NC |
| Paul Tonko | Democratic | NY |
| Ro Khanna | Democratic | CA |
| Robert J. Wittman | Republican | VA |
| Salud O. Carbajal | Democratic | CA |
| Susan Wild | Democratic | PA |
| Theodore E. Deutch | Democratic | FL |
| Thomas R. Suozzi | Democratic | NY |
| Van Taylor | Republican | TX |
| William R. Keating | Democratic | MA |
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Higher education healthcare related issues, generally NIH program related issues Public health and CDC related issues Adolescent Mental Health related issues Telehealth related issues Graduate Medical Education (GME) H.R.2389/S.1302, Resident Physician Shortage Act of 2023, generally H.R.1202/S.704, Resident Education Deferred Interest Act, generally H.R.4942/S.665 The Conrad State 30 and Physician Access Reauthorization Act, generally Monitor the following: Laboratory Developed Tests Organ transplant issues Alabama Area Health Education Centers (AHEC) Nurse reimbursement related issues Hospital at Home Program, Entirety Proposed Cuts to OPPS for Organ Acquisition Cos Disproportionate Share Hospital (DSH) Payments Public Law 117-167, Supreme Court Security Funding Act of 2022, Division A--Creating Helpful Incentives to Produce Semiconductors (CHIPS Act), NSF and Energy related issues Agency for Healthcare Research and Quality related issues IDeA program related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Client expense: $450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Health Issues
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Client expense: $540,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Health Issues
HR 5013 The Value in Health Care Act of 2023 (Lahood, Wenstrup) Extends the ACO Bonus + HR 3173/S3108 (117th Congress) Seniors Timely Access to Care Act + Congressional Bipartisan Dear Colleague letter (Bera) to Secretary Becerra regarding the prior authorization regulations HR 4822 The Health Care Transparency Act of 2023 - Includes HR 3173 Prior Authorization Reform S 1302/HR 2389 The Resident Physician Shortage Reduction Act of 2023 (Schatz, Wicker, Cardin, Thune/Sewell, Fitzpatrick) S 704/HR 1202 The Resident Education Deferred Interest (REDI) Act (Rosen, Boozman/Babin, Houlahan) S 2016/HR 4189 CONNECT for Health Act of 2023 (Telehealth) (Menendez, Boozman, Schumer, Collins/Thompson, Matsui) HR 4941 (Schiff) Providing Access to Treatment and Housing Act of 2023 (PATH Act) HR 4974 (Cardens) Local 988 Response Act of 2023 Mental Health Hotline S 1339 (Sanders, Cassidy) PBM Reform Act HR 4882 Health Care Price Transparency Act of 2023 (physician reporting + HR 3173 Prior Authorization Reform) HR 3784 Providers and Payers Compete Act
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Health Issues
HR 5013 The Value in Health Care Act of 2023 (Lahood, Wenstrup) Extends the ACO Bonus + HR 4822 The Health Care Transparency Act of 2023 - Includes HR 3173 Prior Authorization Reform S 1302/HR 2389 The Resident Physician Shortage Reduction Act of 2023 (Schatz, Wicker, Cardin, Thune/Sewell, Fitzpatrick) S 704/HR 1202 The Resident Education Deferred Interest (REDI) Act (Rosen, Boozman/Babin, Houlahan) S 2016/HR 4189 CONNECT for Health Act of 2023 (Telehealth) (Menendez, Boozman, Schumer, Collins/Thompson, Matsui) Reauthorize the Teaching Health Center Program Reauthorize the Childrens Hospital Graduate Medical Education Program HR 3173/S3108 (117th Congress) Seniors Timely Access to Care Act + Congressional Bipartisan Dear Colleague letter (Bera) to Secretary Becerra regarding the prior authorization regulations HR 4941 (Schiff) Providing Access to Treatment and Housing Act of 2023 (PATH Act) HR 4974 (Cardens) Local 988 Response Act of 2023 Mental Health Hotline S 1339 (Sanders, Cassidy) PBM Reform Act HR 4882 Health Care Price Transparency Act of 2023 (physician reporting + HR 3173 Prior Authorization Reform) HR 3784 Providers and Payers Compete Act CMA letter urging Surgeon General Murthy to publish a Surgeon Generals Report on the public health epidemic of gun violence
Client expense: $55,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Health Issues
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Health Issues
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
Client expense: $160,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Health Issues
S 1302/HR 2389 The Resident Physician Shortage Reduction Act of 2023 (Schatz, Wicker, Cardin, Thune/Sewell, Fitzpatrick) S 2016/HR 4189 CONNECT for Health Act of 2023 (Telehealth) (Menendez, Boozman, Schumer, Collins/Thompson, Matsui) Reauthorize the Teaching Health Center Program HR 3173/S3108 (117th Congress) Seniors Timely Access to Care Act + Congressional Bipartisan Dear Colleague letter (Bera) to Secretary Becerra regarding the prior authorization regulations HR 4941 (Schiff) Providing Access to Treatment and Housing Act of 2023 (PATH Act) HR 4974 (Cardens) Local 988 Response Act of 2023 Mental Health Hotline S 1339 (Sanders, Cassidy) PBM Reform Act HR 4882 Health Care Price Transparency Act of 2023 (physician reporting + HR 3173 Prior Authorization Reform) HR 3784 Providers and Payers Compete Act S 704/HR 1202 (Rosen, Boozman/Babin, Houlahan) Resident Education Deferred Interest (REDI) Act CMA letter urging Surgeon General Murthy to publish a Surgeon Generals Report on the public health epidemic of gun violence.
Client expense: $65,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · second_quarter · Health Issues
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · first_quarter · Health Issues
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · third_quarter · Food Industry (safety, labeling, etc.)
H.R.1202/S.578 Food Allergy Safety, Treatment, Education, and Research Act (FASTER Act) Food Safety Modernization Act, P.L.111-353 Notifications for Food Contact Substances H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 Hemp Access and Consumer Safety Act Cannabis Administration and Opportunity Act (Discussion Draft)
Client expense: $268,959 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Food Industry (safety, labeling, etc.)
H.R.1202/S.578 Food Allergy Safety, Treatment, Education, and Research Act (FASTER Act) Food Safety Modernization Act, P.L.111-353 Notifications for Food Contact Substances H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 Hemp Access and Consumer Safety Act
Client expense: $518,508 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Food Industry (safety, labeling, etc.)
Issues related to the National Bioengineered Food Disclosure Final Rule. Matters affecting the preservation of choice and expansion of benefits in the Supplemental Nutrition Assistance Program (SNAP) during the COVID pandemic. Issues impacting the snack food industry, including nutrition issues such as sodium policy. FASTER Act (S.578/H.R. 1202)
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Food Industry (safety, labeling, etc.)
Food safety and labeling issues. Food and nutrition policy. H.R. 793/S. 255, RESTAURANTS Act of 2021. H.R. 1202/S. 578, FASTER Act of 2021. SNAP legislation. Proposed illegal fishing legislation. Restaurants' role in addressing food insecurity. Country of origin labeling. H.R. 4568, ENTREE Act.
Client expense: $740,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), Treasury, Dept of
2021 · fourth_quarter · Food Industry (safety, labeling, etc.)
S. 578/H.R. 1202 - FASTER Act of 2021; H.R. 2918, Continuous Improvement and Accountability in Organic Standards Act
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Agriculture
Issues related to Farm Bill implementation; organic research; farm labor issues; S. 578/H.R. 1202 - FASTER Act of 2021; H.R. 1602 - Farm Workforce Modernization Act
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Food Industry (safety, labeling, etc.)
Food safety and labeling issues. Food and nutrition policy. H.R. 793/S. 255, RESTAURANTS Act of 2021. H.R. 1202/S. 578, FASTER Act of 2021. SNAP legislation. Proposed illegal fishing legislation. Restaurants' role in addressing food insecurity. Country of origin labeling. H.R. 4568, ENTREE Act.
Client expense: $750,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), Treasury, Dept of
2021 · third_quarter · Food Industry (safety, labeling, etc.)
Issues related to the National Bioengineered Food Disclosure Final Rule. Matters affecting the preservation of choice and expansion of benefits in the Supplemental Nutrition Assistance Program (SNAP) during the COVID pandemic. Issues impacting the snack food industry, including nutrition issues such as sodium policy. FASTER Act (S.578/H.R. 1202)
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2021 · third_quarter · Food Industry (safety, labeling, etc.)
Food safety and labeling issues. Food and nutrition policy. H.R. 793/S. 255, RESTAURANTS Act of 2021. H.R. 1202/S. 578, FASTER Act of 2021. SNAP legislation. Proposed illegal fishing legislation. Restaurants' role in addressing food insecurity. Country of origin labeling. H.R. 4568, ENTREE Act.
Client expense: $750,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), Treasury, Dept of
2021 · second_quarter · Food Industry (safety, labeling, etc.)
H.R.1202/S.578 Food Allergy Safety, Treatment, Education, and Research Act (FASTER Act) Food Safety Modernization Act, P.L.111-353 Notifications for Food Contact Substances H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 Hemp Access and Consumer Safety Act
Client expense: $518,508 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Food Industry (safety, labeling, etc.)
H.R.1202/S.578 Food Allergy Safety, Treatment, Education, and Research Act (FASTER Act) Food Safety Modernization Act, P.L.111-353 Notifications for Food Contact Substances H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 Hemp Access and Consumer Safety Act Cannabis Administration and Opportunity Act (Discussion Draft)
Client expense: $268,959 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), White House Office
2021 · third_quarter · Food Industry (safety, labeling, etc.)
Matters affecting the preservation of choice in Supplemental Nutrition Assistance Program. Issues impacting the snack food industry, including nutrition issues such as sodium policy. FASTER Act (S. 578/H.R. 1202).
Client expense: Not reported · Firm income: $60,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2021 · third_quarter · Agriculture
Issues related to Farm Bill implementation; organic research; farm labor issues; S. 578/H.R. 1202 - FASTER Act of 2021; H.R. 1602 - Farm Workforce Modernization Act
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Food Industry (safety, labeling, etc.)
S. 578/H.R. 1202 - FASTER Act of 2021; H.R. 2918, Continuous Improvement and Accountability in Organic Standards Act
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Food Industry (safety, labeling, etc.)
Issues related to the National Bioengineered Food Disclosure Final Rule. Matters affecting the preservation of choice and expansion of benefits in the Supplemental Nutrition Assistance Program (SNAP) during the COVID pandemic. Issues impacting the snack food industry, including nutrition issues such as sodium policy. FASTER Act (S.578/H.R. 1202)
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Food Industry (safety, labeling, etc.)
Food safety and labeling issues. Food and nutrition policy. H.R. 793/S. 255, RESTAURANTS Act of 2021. H.R. 1202/S. 578, FASTER Act of 2021. SNAP legislation. Proposed illegal fishing legislation. Restaurants' role in addressing food insecurity. Country of origin labeling.
Client expense: $770,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), Treasury, Dept of
2021 · second_quarter · Food Industry (safety, labeling, etc.)
Public Law No: 117-11 (FASTER Act of 2021, S. 578/H.R. 1202) FDA Closer to Zero H.R.2229/S.1019 - Baby Food Safety Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act to limit the presence of toxic elements in, and otherwise regulate, infant and toddler food, and for other purposes. The Hemp Access and Consumer Safety Act (S.1698)
Client expense: $300,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
2021 · second_quarter · Food Industry (safety, labeling, etc.)
H.R.1202/S.578 Food Allergy Safety, Treatment, Education, and Research Act (FASTER Act) Food Safety Modernization Act, P.L.111-353 Notifications for Food Contact Substances H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 Hemp Access and Consumer Safety Act
Client expense: $473,207 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Food Industry (safety, labeling, etc.)
S. 578/H.R. 1202 - FASTER Act of 2021; HR 2918, Continuous Improvement and Accountability in Organic Standards Act
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Agriculture
Issues related to Farm Bill implementation; organic research; farm labor issues; S. 578/H.R. 1202 - FASTER Act of 2021; H.R. 1602 - Farm Workforce Modernization Act
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
HR 1202/S 578, Food Allergy Safety, Treatment, Education and Research (FASTER) Act FY22 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Food Industry (safety, labeling, etc.)
Matters affecting the preservation of choice in Supplemental Nutrition Assistance Program. Issues impacting the snack food industry, including nutrition issues such as sodium policy. FASTER Act (S. 578/H.R. 1202).
Client expense: Not reported · Firm income: $60,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2021 · second_quarter · Food Industry (safety, labeling, etc.)
The FASTER Act, H.R. 1202/S. 578 The Child Nutrition Reauthorization Act
Client expense: $35,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), President of the U.S., SENATE, White House Office
2021 · first_quarter · Food Industry (safety, labeling, etc.)
H.R.1202/S.578 Food Allergy Safety, Treatment, Education, and Research Act (FASTER Act) Food Safety Modernization Act, P.L.111-353 Bioengineered Food Disclosure Act, P.L.114-216
Client expense: $554,346 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Food Industry (safety, labeling, etc.)
Issues related to the National Bioengineered Food Disclosure Final Rule. Matters affecting the preservation of choice and expansion of benefits in the Supplemental Nutrition Assistance Program (SNAP) during the COVID pandemic. Issues impacting the snack food industry, including nutrition issues such as sodium policy. FASTER Act (S.578/H.R. 1202)
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Food Industry (safety, labeling, etc.)
FASTER Act of 2021, S. 578/H.R. 1202 H.R.2229/S.1019 - Baby Food Safety Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act to limit the presence of toxic elements in, and otherwise regulate, infant and toddler food, and for other purposes. COVID-19 Vaccine Prioritization/Eligibility; Pharmacist Scope of Practice
Client expense: $350,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2021 · first_quarter · Food Industry (safety, labeling, etc.)
H.R.1202/S.578 Food Allergy Safety, Treatment, Education, and Research Act (FASTER Act) Food Safety Modernization Act, P.L.111-353 Bioengineered Food Disclosure Act, P.L.114-216
Client expense: $554,346 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Agriculture
Issues related to Farm Bill implementation; organic research; farm labor issues; S. 578/H.R. 1202 - FASTER Act of 2021; H.R. 1602 - Farm Workforce Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Food Industry (safety, labeling, etc.)
S. 578/H.R. 1202 - FASTER Act of 2021
Client expense: Not reported · Firm income: $30,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Health Issues
HR 1202/S 578, Food Allergy Safety, Treatment, Education and Research (FASTER) Act FY22 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Food Industry (safety, labeling, etc.)
Matters affecting the preservation of choice in Supplemental Nutrition Assistance Program. Issues impacting the snack food industry, including nutrition issues such as sodium policy. FASTER Act (S. 578/H.R. 1202).
Client expense: Not reported · Firm income: $60,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2021 · first_quarter · Food Industry (safety, labeling, etc.)
The FASTER Act, H.R. 1202/S. 578
Client expense: $30,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), President of the U.S., SENATE, White House Office